Cargando…
A miRNA-based diagnostic model predicts resectable lung cancer in humans with high accuracy
Lung cancer, the leading cause of cancer death worldwide, is most frequently detected through imaging tests. In this study, we investigated serum microRNAs (miRNAs) as a possible early screening tool for resectable lung cancer. First, we used serum samples from participants with and without lung can...
Autores principales: | Asakura, Keisuke, Kadota, Tsukasa, Matsuzaki, Juntaro, Yoshida, Yukihiro, Yamamoto, Yusuke, Nakagawa, Kazuo, Takizawa, Satoko, Aoki, Yoshiaki, Nakamura, Eiji, Miura, Junichiro, Sakamoto, Hiromi, Kato, Ken, Watanabe, Shun-ichi, Ochiya, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081195/ https://www.ncbi.nlm.nih.gov/pubmed/32193503 http://dx.doi.org/10.1038/s42003-020-0863-y |
Ejemplares similares
-
Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma
por: Ohno, Makoto, et al.
Publicado: (2019) -
Circulating microRNAs: Challenges with their use as liquid biopsy biomarkers
por: Takizawa, Satoko, et al.
Publicado: (2022) -
Serum microRNA-based prediction of responsiveness to eribulin in metastatic breast cancer
por: Satomi-Tsushita, Natsuko, et al.
Publicado: (2019) -
Circulating miRNA panels for specific and early detection in bladder cancer
por: Usuba, Wataru, et al.
Publicado: (2018) -
Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients
por: Miura, Tomofumi, et al.
Publicado: (2022)